Back to results
US 2026/0216353 A1Published application
Antibody-drug conjugate targeting claudin18.2
AssigneeFortvita Biologics (Singapore) Pte. Ltd.
InventorsKaijie HE, Shuaixiang ZHOU, Xiaodan LIU, Jia LU
Life of this patent
Estimating the term…
Abstract
The present invention relates to an antibody-drug conjugate (ADC) targeting Claudin18.2 and a composition containing the molecule. The present invention further relates to therapeutic and diagnostic uses of the antibodies and antibody fragments.
Claims21
1-28. (canceled)
An antibody-drug conjugate comprising the following Formula:
- wherein Ab is an anti-claudin18.2 antibody comprising:
- a HCDR1, HCDR2, and HCDR3 having amino acid sequences set forth in SEQ ID NOs:
- 1, 2, and 3, respectively;
- and
- a LCDR1, LCDR2, and LCDR3 having amino acid sequences set forth in SEQ ID NOs:
- 6, 7, and 8, respectively;
- and
- wherein q is a drug antibody ratio (DAR) from 3 to 5.
5 more elements
An antibody drug-conjugate of the following Formula:
- wherein Ab is an anti-claudin18.2 antibody comprising:
- a heavy chain having the amino acid sequence set forth in SEQ ID NO:
- 11, and
- a light chain having the amino acid sequence set forth in SEQ ID NO:
- 12;
- wherein conjugation to the Ab is at position Asn297;
- and
- q is a DAR from 3 to 4.
5 more elements
Dependencies are inferred from the claim text.